Lybrel (Levonorgestrel and Ethinyl Estradol Tablets) Drug Information: Overdosage and Contraindications

Pill Identifier Search

May 27, 2012

Lybrel

Information on Birth Control Pills »

What are birth control pills and how do they work?

Birth control pills are also known as oral contraceptives (OCs) or, simply, “the pill.” They offer protection against pregnancy by blocking the union of sperm and egg, thereby preventing conception.

Oral contraceptives or birth control pills contain synthetic female hormones. They work largely by preventing the release of an egg from an ovary, or ovulation. If no egg is released, there can be no pregnancy.

Stopping ovulation is not the only way birth control pills can work. The progestin or synthetic progesterone in birth control pills also changes the physical and chemical environment of the female reproductive tract, making it hostile for sperm.

What are the different types of birth control pills?

The active ingredients in birth control pills are synthetic versions of the female hormones estrogen and progesterone. Combination oral contraceptives are birth control...

Read the Information on Birth Control Pills article »

« Previous
1
2
3
4
5
6
7
8
9
10
11
12
13
Next »

Lybrel User Reviews >>

Lybrel

Birth Control Slideshow Pictures

font size

OVERDOSE

Symptoms of oral contraceptive overdosage in adults and children may include nausea, vomiting, breast tenderness, dizziness, abdominal pain, drowsiness/fatigue; withdrawal bleeding may occur in females. There is no specific antidote and further treatment of overdose, if necessary, is directed to the symptoms.

Noncontraceptive Health Benefits

The following noncontraceptive health benefits related to the use of oral contraceptives are supported by epidemiological studies which largely utilized oral contraceptive formulations containing doses exceeding 0.035 mg of ethinyl estradiol or 0.05 mg of mestranol.

Effects on menses

May decrease blood loss and may decrease the incidence of iron-deficiency anemia

May decrease incidence of dysmenorrhea

Effects related to inhibition of ovulation

May decrease incidence of functional ovarian cysts

May decrease incidence of ectopic pregnancies

Effects from long-term use

May decrease incidence of fibroadenomas and fibrocystic disease of the breast

May decrease incidence of acute pelvic inflammatory disease

May decrease incidence of endometrial cancer

May decrease incidence of ovarian cancer

CONTRAINDICATIONS

Combination oral contraceptives should not be used in women with any of the following conditions:

Thrombophlebitis or thromboembolic disorders
History of deep-vein thrombophlebitis or thromboembolic disorders
Cerebrovascular or coronary artery disease (current or past history)
Valvular heart disease with thrombogenic complications
Thrombogenic rhythm disorders
Hereditary or acquired thrombophilias
Major surgery with prolonged immobilization
Diabetes with vascular involvement
Headaches with focal neurological symptoms such as aura
Uncontrolled hypertension
Known or suspected carcinoma of the breast or personal history of breast cancer
Carcinoma of the endometrium or other known or suspected estrogen-dependent neoplasia
Undiagnosed abnormal genital bleeding
Cholestatic jaundice of pregnancy or jaundice with prior pill use
Hepatic adenomas or carcinomas, or active liver disease
Known or suspected pregnancy
Hypersensitivity to any of the components of LYBREL (levonorgestrel and ethinyl estradol tablets)